Electrolarynx Market By Type (Built-in Battery, External Battery), By Application (Laryngeal Cancer, Speech Rehabilitation), By End user (Hospitals, Ambulatory Surgical Centers, others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Electrolarynx Market

Electrolarynx is a medical device. It is the size of about a small electric razor that generates vibration when placed under the skin of the face or neck. An electrolarynx device is one method for voice rehabilitation. This method involves a handheld external device that generates vibration when placed on the skin of the neck or face. The vibrating sound created by the electrolarynx is then shaped by the tongue and lips and converted into understandable speech. It should be noted that the voice produced with the electrolarynx has a somewhat “robotic” sound, which can be modulated to some extent. 

The Electrolarynx Market Trends are an increase in the incidence of laryngeal cancer as well as rising demand for electrolarynx devices. Moreover, a rise in the cases of human papillomavirus infection and a surge in the consumption of alcohol and tobacco, which increase the chance of laryngeal cancer, boosts the growth of the market. For instance, according to the report published by Cancer Net in 2020, it has been reported that around 12,470 adults (9,820 men and 2,650 women) in the U.S. are diagnosed with laryngeal cancer. Thus, the rise in the number of people suffering from laryngeal cancer increases the demand for electrolarynx devices, which propels the Electrolarynx Market Growth. Furthermore, the increasing hypopharyngeal cancer population in India and China has increased the demand for technologically advanced electrolarynx devices, which will provide lucrative opportunities for the growth of the market.

On the basis of type, the electrolarynx market is segmented into external batteries and built-in batteries. In 2021, the built-in battery segment accounted for the largest share of the market. The dominance of this segment can be attributed to the increasing prevalence of laryngeal cancer and the benefits provided by built-in battery electrolarynx devices as the batteries of these types of devices are rechargeable batteries that can be charged again after being discharged, thereby increasing the demand for built-in battery electrolarynx devices. 

On the basis of application, the electrolarynx market is segmented into laryngeal cancer and speech rehabilitation. In 2021, the laryngeal cancer segment accounted for the largest share of the market. The dominance of this segment can be attributed to the rise in the number of populations and the surge in the consumption of alcohol and tobacco which causes laryngeal cancer. 

By end user the Electrolarynx Industry is segmented into hospitals, ambulatory surgical centers, and others, the hospital's segment exhibited the highest growth in 2021, and is anticipated to lead during the forecast period, owing to an increase in the number of patients visiting hospitals for the surgical procedure due to rise in the prevalence of cancer and also, hospitals are better equipped to handle any post-operative complications and they include facilities for physical rehabilitation post surgeries are the key factors that drive the growth of the market in upcoming years.

North America accounted for a majority of the electrolarynx market share in 2021 and is anticipated to remain dominant during the forecast period. Owing to the high adoption rate of technologically advanced electrolarynx devices for laryngeal cancer, the increase in the healthcare expenditure and presence of major key players in the country, and the strategies they adopt for the development of voice restoration products such as electrolarynx devices. 

Asia-Pacific is expected to register the fastest CAGR during the forecast period. The market growth in the Asia-Pacific region is supplemented by the rising consumption of alcohol and tobacco, highly populated countries along with a high rate of active smokers and a high prevalence of hypopharyngeal cancer. In addition, the increasing patient awareness about the availability of technologically advanced voice restoration devices and the presence of high unmet medical needs in these nations, especially in countries such as India and China, are expected to further drive the market growth. 

The key players that operate in the electrolarynx market are Atos Medical, Amplicord, Andreas Fahl Medizintechnik, Griffin Laboratories, NU-Vois, Labaex Trade, InHealth Technologies, Romet, SERVONA GmbH, and ULTRAVOICE Limited. 

Key findings of the study

By type, the built-in battery segment was the highest contributor to the market in 2021.

By application, the laryngeal cancer segment was the highest contributor to the market in 2021.

By end users, the hospital's segment dominated the market in 2021 and is expected to continue this trend during the forecast period.

By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

Overview

The global electrolarynx market was valued at $409.5 million in 2021 and is projected to reach $703.0 million by 2031, registering a CAGR of 5.5% from 2022 to 2031. An electronic larynx (electrolarynx) is battery-powered equipment that generates sound so that a person can speak. There are various makes and models, but they are typically the size of a small electric razor. When a person wants to talk, this little, battery-operated gadget is put right on the neck, beneath the chin. The electrolarynx produces a vibration that is sent via the skin to the throat when a person presses a button on the device. With the mouth, tongue, lips, and teeth, the patient forms this sound into words.

The artificial larynx device allows individuals who have lost their voice to adjust and save several sound frequency parameters to produce improved speech. Voice restoration devices are most utilized after a laryngectomy, in which the whole voice box, known as the larynx, is permanently removed, separating the windpipe and food pipe.

The key factors that drive the growth of the market are the rise in the prevalence of laryngeal cancer and the surge in the consumption of alcohol and tobacco are the major factors drive the electrolarynx market. For instance, according to the report published by the American Cancer Society, it has been estimated for laryngeal cancer in the U.S. for 2022 that, about 12,470 new cases of laryngeal cancer (9,820 in men and 2,650 in women) were recorded in about 3,820 people (3,070 men and 750 women) died from laryngeal cancer. Furthermore, the increase in the cases of respiratory papilloma which is caused by the human papillomavirus (HPV) is usually benign (non-cancerous). These growths can lead to vocal cord damage and airway problems, which increases the demand for electrolarynx devices hence propelling the growth of the market. Moreover, the high adoption of these medical devices and continuously investing in R&D by numerous key players for the launch of innovative and technologically advanced electrolarynx devices are anticipated to fuel the market growth.

However, the high cost of electrolarynx devices hampers market growth. Conversely, rising cases of hypopharyngeal cancer, the emerging healthcare market in developing countries, and low-income countries lacking access to basic healthcare, and an increase in the risk of laryngeal cancer are expected to provide a lucrative opportunity for the growth of the market during the forecast period. 

The electrolarynx market is segmented on the basis of type, application, end-user, and region. By type, the market is segmented into external batteries and built-in batteries. By application, it is bifurcated into laryngeal cancer and speech rehabilitation. By end user, the market is segmented into hospitals, ambulatory surgical centers, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America accounted for a majority of the electrolarynx market share in 2021 and is anticipated to remain dominant during the forecast period. The electrolarynx market is mainly driven by the presence of well-established healthcare facilities and a high prevalence rate of laryngeal cancer. Moreover, an increase in the number of people consuming alcohol and tobacco and a rise in the demand for electrolarynx devices are contributing to the market growth in the region. Furthermore, an increasing number of key players in this region are involved in R&D activities for the development of technologically advanced medical devices, and the initiatives being undertaken by various organizations to spread awareness and reduce the prevalence rate of hypopharyngeal cancer through innovative research are expected to fuel the market growth.

Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the presence of high unmet medical needs and constantly improving healthcare infrastructure. In addition, the rapidly growing population, various lifestyle changes such as the high rate of people consuming alcohol and tobacco, rising incidence of laryngeal cancer, improvement in the quality of diagnosis, and increasing patient affordability are set to drive the market in the Asia-Pacific region. This helps several market players to invest in Asia-Pacific countries, which in turn will further contribute to the growth of the market.

The key players that operate in the electrolarynx market are Atos Medical, Amplicord, Fountain Head Marketing, Inc., Medline Industries, Nu Vois, Labaex, InHealth Technologies, Romet, Servona GmbH, Luminaud, and Ultravoice.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the electrolarynx market analysis from 2021 to 2031 to identify the prevailing electrolarynx market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the electrolarynx market segmentation assists in determining the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes an analysis of the regional as well as global electrolarynx market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Atos Medical A

Scope of Electrolarynx Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Built-in Battery

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market share analysis by country

4.3 External Battery

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market share analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Laryngeal Cancer

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market share analysis by country

5.3 Speech Rehabilitation

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market share analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Hospitals

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market share analysis by country

6.3 Ambulatory Surgical Centers

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market share analysis by country

6.4 others

6.4.1 Key market trends, growth factors and opportunities

6.4.2 Market size and forecast, by region

6.4.3 Market share analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by Type

7.2.3 North America Market size and forecast, by Application

7.2.4 North America Market size and forecast, by End user

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Key market trends, growth factors and opportunities

7.2.5.1.2 Market size and forecast, by Type

7.2.5.1.3 Market size and forecast, by Application

7.2.5.1.4 Market size and forecast, by End user

7.2.5.2 Canada

7.2.5.2.1 Key market trends, growth factors and opportunities

7.2.5.2.2 Market size and forecast, by Type

7.2.5.2.3 Market size and forecast, by Application

7.2.5.2.4 Market size and forecast, by End user

7.2.5.3 Mexico

7.2.5.3.1 Key market trends, growth factors and opportunities

7.2.5.3.2 Market size and forecast, by Type

7.2.5.3.3 Market size and forecast, by Application

7.2.5.3.4 Market size and forecast, by End user

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by Type

7.3.3 Europe Market size and forecast, by Application

7.3.4 Europe Market size and forecast, by End user

7.3.5 Europe Market size and forecast, by country

7.3.5.1 Germany

7.3.5.1.1 Key market trends, growth factors and opportunities

7.3.5.1.2 Market size and forecast, by Type

7.3.5.1.3 Market size and forecast, by Application

7.3.5.1.4 Market size and forecast, by End user

7.3.5.2 France

7.3.5.2.1 Key market trends, growth factors and opportunities

7.3.5.2.2 Market size and forecast, by Type

7.3.5.2.3 Market size and forecast, by Application

7.3.5.2.4 Market size and forecast, by End user

7.3.5.3 UK

7.3.5.3.1 Key market trends, growth factors and opportunities

7.3.5.3.2 Market size and forecast, by Type

7.3.5.3.3 Market size and forecast, by Application

7.3.5.3.4 Market size and forecast, by End user

7.3.5.4 Italy

7.3.5.4.1 Key market trends, growth factors and opportunities

7.3.5.4.2 Market size and forecast, by Type

7.3.5.4.3 Market size and forecast, by Application

7.3.5.4.4 Market size and forecast, by End user

7.3.5.5 Spain

7.3.5.5.1 Key market trends, growth factors and opportunities

7.3.5.5.2 Market size and forecast, by Type

7.3.5.5.3 Market size and forecast, by Application

7.3.5.5.4 Market size and forecast, by End user

7.3.5.6 Rest of Europe

7.3.5.6.1 Key market trends, growth factors and opportunities

7.3.5.6.2 Market size and forecast, by Type

7.3.5.6.3 Market size and forecast, by Application

7.3.5.6.4 Market size and forecast, by End user

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by Type

7.4.3 Asia-Pacific Market size and forecast, by Application

7.4.4 Asia-Pacific Market size and forecast, by End user

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 Japan

7.4.5.1.1 Key market trends, growth factors and opportunities

7.4.5.1.2 Market size and forecast, by Type

7.4.5.1.3 Market size and forecast, by Application

7.4.5.1.4 Market size and forecast, by End user

7.4.5.2 China

7.4.5.2.1 Key market trends, growth factors and opportunities

7.4.5.2.2 Market size and forecast, by Type

7.4.5.2.3 Market size and forecast, by Application

7.4.5.2.4 Market size and forecast, by End user

7.4.5.3 Australia

7.4.5.3.1 Key market trends, growth factors and opportunities

7.4.5.3.2 Market size and forecast, by Type

7.4.5.3.3 Market size and forecast, by Application

7.4.5.3.4 Market size and forecast, by End user

7.4.5.4 India

7.4.5.4.1 Key market trends, growth factors and opportunities

7.4.5.4.2 Market size and forecast, by Type

7.4.5.4.3 Market size and forecast, by Application

7.4.5.4.4 Market size and forecast, by End user

7.4.5.5 South Korea

7.4.5.5.1 Key market trends, growth factors and opportunities

7.4.5.5.2 Market size and forecast, by Type

7.4.5.5.3 Market size and forecast, by Application

7.4.5.5.4 Market size and forecast, by End user

7.4.5.6 Rest of Asia-Pacific

7.4.5.6.1 Key market trends, growth factors and opportunities

7.4.5.6.2 Market size and forecast, by Type

7.4.5.6.3 Market size and forecast, by Application

7.4.5.6.4 Market size and forecast, by End user

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by Type

7.5.3 LAMEA Market size and forecast, by Application

7.5.4 LAMEA Market size and forecast, by End user

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Brazil

7.5.5.1.1 Key market trends, growth factors and opportunities

7.5.5.1.2 Market size and forecast, by Type

7.5.5.1.3 Market size and forecast, by Application

7.5.5.1.4 Market size and forecast, by End user

7.5.5.2 Saudi Arabia

7.5.5.2.1 Key market trends, growth factors and opportunities

7.5.5.2.2 Market size and forecast, by Type

7.5.5.2.3 Market size and forecast, by Application

7.5.5.2.4 Market size and forecast, by End user

7.5.5.3 South Africa

7.5.5.3.1 Key market trends, growth factors and opportunities

7.5.5.3.2 Market size and forecast, by Type

7.5.5.3.3 Market size and forecast, by Application

7.5.5.3.4 Market size and forecast, by End user

7.5.5.4 Rest of LAMEA

7.5.5.4.1 Key market trends, growth factors and opportunities

7.5.5.4.2 Market size and forecast, by Type

7.5.5.4.3 Market size and forecast, by Application

7.5.5.4.4 Market size and forecast, by End user

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 Ultravoice Limited

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 Inhealth Technologies

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 Griffin Labs

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4 Servona GmbH

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 Labex Trade

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 AMPLICORD DI GABRIELLA SALVATORE

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 Romet Limted

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 Nu-Vois, LLC

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 Andreas Fahl Medizintechnik - Vertrieb GmbH

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 Atos Medical AB

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 2. ELECTROLARYNX MARKET FOR BUILT-IN BATTERY, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 3. ELECTROLARYNX MARKET FOR BUILT-IN BATTERY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 4. ELECTROLARYNX MARKET FOR EXTERNAL BATTERY, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 5. ELECTROLARYNX MARKET FOR EXTERNAL BATTERY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 6. GLOBAL ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 7. ELECTROLARYNX MARKET FOR LARYNGEAL CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 8. ELECTROLARYNX MARKET FOR LARYNGEAL CANCER, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 9. ELECTROLARYNX MARKET FOR SPEECH REHABILITATION, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 10. ELECTROLARYNX MARKET FOR SPEECH REHABILITATION, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 11. GLOBAL ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 12. ELECTROLARYNX MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 13. ELECTROLARYNX MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 14. ELECTROLARYNX MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 15. ELECTROLARYNX MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 16. ELECTROLARYNX MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 17. ELECTROLARYNX MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 18. ELECTROLARYNX MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 19. NORTH AMERICA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 20. NORTH AMERICA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 21. NORTH AMERICA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 22. NORTH AMERICA ELECTROLARYNX MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 23. U.S. ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 24. U.S. ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 25. U.S. ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 26. CANADA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 27. CANADA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 28. CANADA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 29. MEXICO ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 30. MEXICO ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 31. MEXICO ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 32. EUROPE ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 33. EUROPE ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 34. EUROPE ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 35. EUROPE ELECTROLARYNX MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 36. GERMANY ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 37. GERMANY ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 38. GERMANY ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 39. FRANCE ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 40. FRANCE ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 41. FRANCE ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 42. UK ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 43. UK ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 44. UK ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 45. ITALY ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 46. ITALY ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 47. ITALY ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 48. SPAIN ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 49. SPAIN ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 50. SPAIN ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 51. REST OF EUROPE ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 52. REST OF EUROPE ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 53. REST OF EUROPE ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 54. ASIA-PACIFIC ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 55. ASIA-PACIFIC ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 56. ASIA-PACIFIC ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 57. ASIA-PACIFIC ELECTROLARYNX MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 58. JAPAN ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 59. JAPAN ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 60. JAPAN ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 61. CHINA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 62. CHINA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 63. CHINA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 64. AUSTRALIA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 65. AUSTRALIA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 66. AUSTRALIA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 67. INDIA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 68. INDIA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 69. INDIA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 70. SOUTH KOREA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 71. SOUTH KOREA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 72. SOUTH KOREA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 73. REST OF ASIA-PACIFIC ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 74. REST OF ASIA-PACIFIC ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 75. REST OF ASIA-PACIFIC ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 76. LAMEA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 77. LAMEA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 78. LAMEA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 79. LAMEA ELECTROLARYNX MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 80. BRAZIL ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 81. BRAZIL ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 82. BRAZIL ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 83. SAUDI ARABIA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 84. SAUDI ARABIA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 85. SAUDI ARABIA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 86. SOUTH AFRICA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 87. SOUTH AFRICA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 88. SOUTH AFRICA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 89. REST OF LAMEA ELECTROLARYNX MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 90. REST OF LAMEA ELECTROLARYNX MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 91. REST OF LAMEA ELECTROLARYNX MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)

TABLE 92.ULTRAVOICE LIMITED: COMPANY SNAPSHOT

TABLE 93.ULTRAVOICE LIMITED: OPERATING SEGMENTS

TABLE 94.ULTRAVOICE LIMITED: PRODUCT PORTFOLIO

TABLE 95.ULTRAVOICE LIMITED: NET SALES

TABLE 96.ULTRAVOICE LIMITED: KEY STRATERGIES

TABLE 97.INHEALTH TECHNOLOGIES: COMPANY SNAPSHOT

TABLE 98.INHEALTH TECHNOLOGIES: OPERATING SEGMENTS

TABLE 99.INHEALTH TECHNOLOGIES: PRODUCT PORTFOLIO

TABLE 100.INHEALTH TECHNOLOGIES: NET SALES

TABLE 101.INHEALTH TECHNOLOGIES: KEY STRATERGIES

TABLE 102.GRIFFIN LABS: COMPANY SNAPSHOT

TABLE 103.GRIFFIN LABS: OPERATING SEGMENTS

TABLE 104.GRIFFIN LABS: PRODUCT PORTFOLIO

TABLE 105.GRIFFIN LABS: NET SALES

TABLE 106.GRIFFIN LABS: KEY STRATERGIES

TABLE 107.SERVONA GMBH: COMPANY SNAPSHOT

TABLE 108.SERVONA GMBH: OPERATING SEGMENTS

TABLE 109.SERVONA GMBH: PRODUCT PORTFOLIO

TABLE 110.SERVONA GMBH: NET SALES

TABLE 111.SERVONA GMBH: KEY STRATERGIES

TABLE 112.LABEX TRADE: COMPANY SNAPSHOT

TABLE 113.LABEX TRADE: OPERATING SEGMENTS

TABLE 114.LABEX TRADE: PRODUCT PORTFOLIO

TABLE 115.LABEX TRADE: NET SALES

TABLE 116.LABEX TRADE: KEY STRATERGIES

TABLE 117.AMPLICORD DI GABRIELLA SALVATORE: COMPANY SNAPSHOT

TABLE 118.AMPLICORD DI GABRIELLA SALVATORE: OPERATING SEGMENTS

TABLE 119.AMPLICORD DI GABRIELLA SALVATORE: PRODUCT PORTFOLIO

TABLE 120.AMPLICORD DI GABRIELLA SALVATORE: NET SALES

TABLE 121.AMPLICORD DI GABRIELLA SALVATORE: KEY STRATERGIES

TABLE 122.ROMET LIMTED: COMPANY SNAPSHOT

TABLE 123.ROMET LIMTED: OPERATING SEGMENTS

TABLE 124.ROMET LIMTED: PRODUCT PORTFOLIO

TABLE 125.ROMET LIMTED: NET SALES

TABLE 126.ROMET LIMTED: KEY STRATERGIES

TABLE 127.NU-VOIS, LLC: COMPANY SNAPSHOT

TABLE 128.NU-VOIS, LLC: OPERATING SEGMENTS

TABLE 129.NU-VOIS, LLC: PRODUCT PORTFOLIO

TABLE 130.NU-VOIS, LLC: NET SALES

TABLE 131.NU-VOIS, LLC: KEY STRATERGIES

TABLE 132.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: COMPANY SNAPSHOT

TABLE 133.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: OPERATING SEGMENTS

TABLE 134.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: PRODUCT PORTFOLIO

TABLE 135.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: NET SALES

TABLE 136.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH: KEY STRATERGIES

TABLE 137.ATOS MEDICAL AB: COMPANY SNAPSHOT

TABLE 138.ATOS MEDICAL AB: OPERATING SEGMENTS

TABLE 139.ATOS MEDICAL AB: PRODUCT PORTFOLIO

TABLE 140.ATOS MEDICAL AB: NET SALES

TABLE 141.ATOS MEDICAL AB: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.ELECTROLARYNX MARKET SEGMENTATION

FIGURE 2.ELECTROLARYNX MARKET,2021-2031

FIGURE 3.ELECTROLARYNX MARKET,2021-2031

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.ELECTROLARYNX MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.ELECTROLARYNX MARKET,BY TYPE,2021(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BUILT-IN BATTERY ELECTROLARYNX MARKET,2021-2031(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF EXTERNAL BATTERY ELECTROLARYNX MARKET,2021-2031(%)

FIGURE 15.ELECTROLARYNX MARKET,BY APPLICATION,2021(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF LARYNGEAL CANCER ELECTROLARYNX MARKET,2021-2031(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF SPEECH REHABILITATION ELECTROLARYNX MARKET,2021-2031(%)

FIGURE 18.ELECTROLARYNX MARKET,BY END USER,2021(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HOSPITALS ELECTROLARYNX MARKET,2021-2031(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS ELECTROLARYNX MARKET,2021-2031(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS ELECTROLARYNX MARKET,2021-2031(%)

FIGURE 22.ELECTROLARYNX MARKET BY REGION,2021

FIGURE 23.U.S. ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 24.CANADA ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 25.MEXICO ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 26.GERMANY ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 27.FRANCE ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 28.UK ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 29.ITALY ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 30.SPAIN ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 31.REST OF EUROPE ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 32.JAPAN ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 33.CHINA ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 34.AUSTRALIA ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 35.INDIA ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 36.SOUTH KOREA ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 37.REST OF ASIA-PACIFIC ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 38.BRAZIL ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 39.SAUDI ARABIA ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 40.SOUTH AFRICA ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 41.REST OF LAMEA ELECTROLARYNX MARKET,2021-2031($MILLION)

FIGURE 42. TOP WINNING STRATEGIES, BY YEAR

FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 46.COMPETITIVE DASHBOARD

FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 48.ULTRAVOICE LIMITED.: NET SALES ($MILLION)

FIGURE 49.INHEALTH TECHNOLOGIES.: NET SALES ($MILLION)

FIGURE 50.GRIFFIN LABS.: NET SALES ($MILLION)

FIGURE 51.SERVONA GMBH.: NET SALES ($MILLION)

FIGURE 52.LABEX TRADE.: NET SALES ($MILLION)

FIGURE 53.AMPLICORD DI GABRIELLA SALVATORE.: NET SALES ($MILLION)

FIGURE 54.ROMET LIMTED.: NET SALES ($MILLION)

FIGURE 55.NU-VOIS, LLC.: NET SALES ($MILLION)

FIGURE 56.ANDREAS FAHL MEDIZINTECHNIK - VERTRIEB GMBH.: NET SALES ($MILLION)

FIGURE 57.ATOS MEDICAL AB.: NET SALES ($MILLION